IDH1 and acute myeloid leukemia: IDH1 mutations were first described in central tumors and acute myeloid leukemia (AML), and then in the number of hematopoietic neoplasms (myelodysplastic syndrome, T cell lymphoma) and sarcomas (chondrosarcoma, central chordoma, periosteal chondroma) [158].